Approval Year
Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Fri Dec 15 19:40:36 GMT 2023
by
admin
on
Fri Dec 15 19:40:36 GMT 2023
|
Source Materials Class | ORGANISM |
Source Materials Type | HUMAN |
Source Materials Parent | |
Part | BLOOD |
Fraction Name | PROTEIN IMMUNOGLOBULINS, IGG |
Record UNII |
48W7181FLP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ESSENTIAL MEDICINES LIST |
19.2
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
||
|
NDF-RT |
N0000184165
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
||
|
FDA ORPHAN DRUG |
74993
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
||
|
NCI_THESAURUS |
C2701
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB12028MIG
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | |||
|
SUB127252
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | |||
|
48W7181FLP
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | |||
|
48W7181FLP
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | |||
|
N0000184012
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | Endogenous Antigen Neutralization [MoA] | ||
|
35465
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
ALTERNATIVE | RxNorm | ||
|
1789837
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | |||
|
N0000007920
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | Immunoglobulins [Chemical/Ingredient] | ||
|
DB11597
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | |||
|
N0000183365
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY | Passively Acquired Immunity [PE] | ||
|
C80832
Created by
admin on Fri Dec 15 19:40:36 GMT 2023 , Edited by admin on Fri Dec 15 19:40:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Agent Modifications
Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
---|---|---|---|---|---|
TARGETED ANTIGEN | IMMUNOLOGICAL |
|
BLOOD GROUP RH(D) POLYPEPTIDE | 16YYC73841 |